CNTA – centessa pharmaceuticals plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Centessa Pharmaceuticals (CNTA) was downgraded by Truist Financial Corporation from "buy" to "hold". They now have a $38.00 price target on the stock.
Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public Shareholders
Centessa Pharmaceuticals (CNTA) had its "neutral" rating reaffirmed by Guggenheim.
Centessa Pharmaceuticals (CNTA) was downgraded by B. Riley Financial, Inc. from "strong-buy" to "hold".
Centessa Pharmaceuticals (CNTA) was downgraded by Lifesci Capital from "strong-buy" to "hold".
Form PREM14A Centessa Pharmaceuticals For: Apr 17
Form DEFA14A Centessa Pharmaceuticals
Form DEFA14A Centessa Pharmaceuticals
Form DEFA14A Centessa Pharmaceuticals
Form DEFA14A Centessa Pharmaceuticals
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.